A phase I study of daily afatinib, an irreversible ErbB family blocker, in combination with weekly paclitaxel in patients with advanced solid tumours (Q40619193)
Jump to navigation
Jump to search
scientific article published on 18 August 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase I study of daily afatinib, an irreversible ErbB family blocker, in combination with weekly paclitaxel in patients with advanced solid tumours |
scientific article published on 18 August 2015 |
Statements
1 reference
A phase I study of daily afatinib, an irreversible ErbB family blocker, in combination with weekly paclitaxel in patients with advanced solid tumours (English)
1 reference
A Suder
1 reference
J E Ang
1 reference
F Kyle
1 reference
D Harris
1 reference
S Rudman
1 reference
R Kristeleit
1 reference
F Solca
1 reference
M Uttenreuther-Fischer
1 reference
K Pemberton
1 reference
K Pelling
1 reference
D Schnell
1 reference
J de Bono
1 reference
J Spicer
1 reference
18 August 2015
1 reference
1 reference
51
1 reference
16
1 reference
2275-2284
1 reference
Identifiers
1 reference
1 reference